Position in IQV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,489,339
New position
Shares Held
7,708
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#456
of 1,082 holders
Holding Since
Jun 2026
1 quarter on record
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SNS Financial Group, LLC holds $5,135,597 across 7 Diagnostics & Research names. IQV ranks #2 (29.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,764 | $1,887,119 | |
| 2 | IQV |
Iqvia Holdings Inc.
This page
|
7,708 | $1,489,339 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,293 | $680,686 | |
| 4 | DHR |
Danaher Corp /De/
|
2,413 | $459,628 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
949 | $215,223 | |
| 6 | WAT |
Waters Corp /De/
|
541 | $202,896 | |
| 7 | A |
Agilent Technologies, Inc.
|
1,511 | $200,706 |
All Filings in IQV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,489,339 | 7,708 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||